Answers are grounded in this paper and cite their sources.
Spleen qi deficiency syndrome (SDS) is characterized by chronic fatigue, gastrointestinal dysfunction, and systemic metabolic disturbances and has been associated with gut microbial dysbiosis and chronic inflammation. This study evaluated the effects of two probiotic strains, Limosilactobacillus fermentum Perfectus001 (LFP) and Bifidobacterium animalis subsp. lactis Perfectus006 (BAP), in an SDS rat model. Both probiotic strains significantly ameliorated SDS-like phenotypes, including reduced blood lactate levels, improved endurance-related performance, and improved liver injury markers, as reflected by decreased serum ALT and AST levels. Gut microbiota profiling by 16 S rRNA gene sequencing revealed that LFP and BAP alleviated SDS-associated gut microbial dysbiosis by reducing Escherichia–Shigella , while increasing probiotic-responsive genera, such as Alistipes (adjusted p < 0.05). BAP also increased Parabacteroides relative to the model group. Colonic transcriptomic analysis showed that both strains attenuated inflammatory responses, with BAP more prominently reducing the expression of immune-related genes, including Il - 12b , Il - 17ra , and Il - 17rb . Hepatic transcriptomics further demonstrated distinct probiotic activities, with BAP preferentially suppressing inflammatory pathways, whereas LFP was associated with alterations in lipid and energy metabolism. Serum metabolomics showed that both strains partially corrected SDS-associated metabolic disturbances, including changes in biotin sulfone and several lipid- or bile acid-related metabolites. Integrated microbiota-metabolite correlation analysis further suggested that both probiotics influenced amino acid-related metabolism, particularly beta-alanine metabolism. Collectively, these findings demonstrate that LFP and BAP shared beneficial effects on SDS-associated phenotypes but differed in their modulation of gut microbiota and host responses, supporting their potential application as targeted probiotic interventions for improving gut health and immune homeostasis.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: